Skip to main content
PMC home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2010 Apr 27;6(2):131–134. doi: 10.1007/s13181-010-0061-2

Massive Ethylene Glycol Ingestion Treated with Fomepizole Alone—A Viable Therapeutic Option

Jennie A Buchanan 1,2,✉, Mohammed Alhelail 1,2,4, Edward W Cetaruk 1,2,3, Tammi H Schaeffer 1,2,3, Robert B Palmer 1,2,3, Ken Kulig 3, Jeffrey Brent 2,3
PMCID: PMC3550287  PMID: 20422336

Abstract

Fomepizole is used to treat and prevent toxicity from ethylene glycol poisoning. Treatment with fomepizole without hemodialysis in massive ethylene glycol ingestion has been rarely reported in the literature; however, published literature and practice guidelines recommend considering dialysis for ethylene glycol levels >50 mg/dL. We report a case of massive ethylene glycol ingestion resulting in the highest serum ethylene glycol concentration in a patient without ethanol co-ingestion who was treated with fomepizole and was not hemodialyzed. A 48-year-old male presented to the emergency department after reportedly ingesting >1liter of antifreeze in an attempt at self-harm. He denied concomitant ethanol consumption. His initial presenting serum ethylene glycol level was 700 mg/dL, with normal renal function, and a metabolic acidosis with a high anion gap. One hour after presentation, he was started on intravenous fomepizole. Treatment with fomepizole continued until the patient's plasma ethylene glycol concentration was 16 mg/dL. His metabolic acidosis quickly resolved, he had no adverse reactions to the treatment, and his renal function remained normal. Ultimately, he was discharged to a psychiatric unit without sequelae. Published literature and practice guidelines suggests considering hemodialysis initiation in patients with an ethylene glycol level >50 mg/dL. This recommendation is anecdotally, rather than evidence, based. With the potential risks inherent in hemodialysis, our case provides evidence that treatment with fomepizole without hemodialysis appears to be a viable alternative option in patients with even extremely high plasma ethylene glycol concentrations as long as their renal function is intact.

Keywords: Ethylene glycol, Fomepizole, Hemodialysis, Overdose

Full Text

The Full Text of this article is available as a PDF (106.0 KB).

Acknowledgments

Funding support

None.

References

  • 1.Bronstein AC, Spyker DA, Cantilena LR, Jr, Green J, Rumack BH, Heard SE. Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS) Clin Toxicol (Phila) 2007;45:815–917. doi: 10.1080/15563650701754763. [DOI] [PubMed] [Google Scholar]
  • 2.Jacobsen D. Ethylene glycol and other glycols. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, editors. Critical care toxicology diagnosis and management of the critically poisoned patient. Philadelphia: Elsevier Mosby; 2005. pp. 869–880. [Google Scholar]
  • 3.Hantson P, Wittebole X, Haufroid V. Ethanol therapy for methanol poisoning: duration and problems. Euro J Emerg Med. 2002;9:278–279. doi: 10.1097/00063110-200209000-00015. [DOI] [PubMed] [Google Scholar]
  • 4.Oker EE, Kanji SA, Aks S, Fishbein C, Crockett M. Can health care workers effectively administer ethanol drips? Acad Emerg Med. 2001;8:443. [Google Scholar]
  • 5.Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning. Clin Toxicol. 1997;35:127–143. doi: 10.3109/15563659709001182. [DOI] [PubMed] [Google Scholar]
  • 6.Palatnick W, Redman LW, Sitar DS, Tenenbein M. Methanol half-life during ethanol administration: implications for management of methanol poisoning. Ann Emerg Med. 1995;26:202–207. doi: 10.1016/s0196-0644(95)70152-4. [DOI] [PubMed] [Google Scholar]
  • 7.Boyer EW, Mejia M, Woolf A, Shannon M. Severe ethylene glycol ingestion treated without hemodialysis. Peds. 2001;107:172–174. doi: 10.1542/peds.107.1.172. [DOI] [PubMed] [Google Scholar]
  • 8.Salaspuro MP, Pikkarainen P, Lindros K. Ethanol-induced hypoglycaemia in man: its suppression by the alcohol dehydrogenase inhibitor 4-methylprazole. Eur J Clin Investig. 1977;7:487–490. doi: 10.1111/j.1365-2362.1977.tb01640.x. [DOI] [PubMed] [Google Scholar]
  • 9.Brent J, McMartin K, Phillips S, Burkhart K, Donovan W, Wells M, et al. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med. 1999;340:832–838. doi: 10.1056/NEJM199903183401102. [DOI] [PubMed] [Google Scholar]
  • 10.Wallemacq PE, Vanbinst R, Haufroid V, DiFazio V, Konig J, Detaille T, et al. Plasma and tissue determination of 4-methylpyrazole for pharmacokinetic analysis in acute adult and pediatric methanol/ethylene glycol poisoning. Ther Drug Monit. 2004;26:258–262. doi: 10.1097/00007691-200406000-00006. [DOI] [PubMed] [Google Scholar]
  • 11.Jacobsen D, Barron SK, Sebastian CS, Blomstrand R, McMartin KE. Non-linear kinetics of 4-methylpyrazole in healthy human subjects. Eur J Clin Pharmacol. 1989;37:599–604. doi: 10.1007/BF00562552. [DOI] [PubMed] [Google Scholar]
  • 12.Brent J, McMartin K, Phillips S, Aaron C, Kulig K. Methylpyrazole for Toxic Alcohols Study Group. Fomepizole for the treatment of methanol poisoning. N Eng J Med. 2001;344:424–429. doi: 10.1056/NEJM200102083440605. [DOI] [PubMed] [Google Scholar]
  • 13.Borron SW, Mégarbane B, Baud FJ. Fomepizole in treatment of uncomplicated ethylene glycol poisoning. Lancet. 1999;354:831. doi: 10.1016/S0140-6736(99)80015-4. [DOI] [PubMed] [Google Scholar]
  • 14.Megarbane B, Borron SW, Trout H, Hantson P, Jaeger A, Krencker E, et al. Treatment of acute methanol poisoning with fomepizole. Int Care Med. 2001;27:1370–1378. doi: 10.1007/s001340101011. [DOI] [PubMed] [Google Scholar]
  • 15.Barceloux DG, Krenzelok EP, Olson K, Watson W. American Academy of Clinical Toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad Hoc Committee. J Toxicol Clin Toxicol. 1999;37:537–560. doi: 10.1081/clt-100102445. [DOI] [PubMed] [Google Scholar]
  • 16.Velez LI, Sheperd G, Lee YC, et al. Ethylene glycol ingestion treated only with fomepizole. J Med Toxicol. 2007;3:125–128. doi: 10.1007/BF03160922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Harry P, Jobard E, Briand M, Caubet A, Turcant A. Ethylene glycol poisoning in a child treated with 4-methylpyrazole. Peds. 1998;102:E31. doi: 10.1542/peds.102.3.e31. [DOI] [PubMed] [Google Scholar]
  • 18.Detaille T, Wallemacq P, Clement de Clety S, Vanbinst R, Dembour G, Hantson P. Fomepizole alone for severe infant ethylene glycol poisoning. Pediatr Crit Care Med. 2004;5:490–491. doi: 10.1097/01.PCC.0000128600.17670.FF. [DOI] [PubMed] [Google Scholar]
  • 19.Aakervik O, Svendsen J, Jacobsen D. Severe ethylene glycol poisoning treated with fomepizole (4-methylpyrazole) Tidsskr Nor Laegeforen. 2002;122(25):2444–2446. [PubMed] [Google Scholar]
  • 20.Georg M, Al-Duaij N, Becker ML, Ewald MB. Re: ethylene glycol ingestion treated only with fomepizole (Journal of Medical Toxicology: Volume 3, Number 3, September 2007; 125-8) J Med Toxicol. 2008;4(1):67. doi: 10.1007/BF03160955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jacobsen D, Ovrebo S, Ostborg J, Sejersted OM. Glycolate causes the acidosis in ethylene glycol poisoning and is effectively removed by hemodialysis. Acta Med Scant. 1984;216:409–416. [PubMed] [Google Scholar]
  • 22.Clay KL, Murphy RC. On the metabolic acidosis of ethylene glycol intoxication. Toxicol Appl Pharmacol. 1977;39:39–49. doi: 10.1016/0041-008x(77)90175-2. [DOI] [PubMed] [Google Scholar]
  • 23.Corley RA, Wilson DM, Hard GC, Stebbins KE, Bartels MJ, Soelberg JJ, et al. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity. Toxicol Appl Pharmacol. 2008;228:165–178. doi: 10.1016/j.taap.2007.11.024. [DOI] [PubMed] [Google Scholar]
  • 24.Sivilotti ML, Burns MJ, McMartin KE, Brent J. Toxicokinetics of ethylene glycol during fomepizole therapy: implications for management. For the Methylpyrazole for Toxic Alcohols Study Group. Ann Emerg Med. 2000;36:114–125. doi: 10.1067/mem.2000.107002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES